MedPath

Tocopherol

Generic Name
Tocopherol
Drug Type
Small Molecule
CAS Number
1406-66-2
Unique Ingredient Identifier
R0ZB2556P8
Background

Tocopherol exists in four different forms designated as α, β, δ, and γ. They present strong antioxidant activities, and it is determined as the major form of vitamin E. Tocopherol, as a group, is composed of soluble phenolic compounds that consist of a chromanol ring and a 16-carbon phytyl chain. The classification of the tocopherol molecules is designated depending on the number and position of the methyl substituent in the chromanol ring. The different types of tocopherol can be presented trimethylated, dimethylated or methylated in the positions 5-, 7- and 8-. When the carbons at position 5- and 7- are not methylated, they can function as electrophilic centers that can trap reactive oxygen and nitrogen species. Tocopherols can be found in the diet as part of vegetable oil such as corn, soybean, sesame, and cottonseed. It is currently under the list of substances generally recognized as safe (GRAS) in the FDA for the use of human consumption.

Indication

Tocopherol can be used as a dietary supplement for patients with a deficit of vitamin E; this is mainly prescribed in the alpha form. Vitamin E deficiency is rare, and it is primarily found in premature babies of very low birth weight, patients with fat malabsorption or patients with abetalipoproteinemia.

Tocopherol, due to its antioxidant properties, is studied for its use in prevention or treatment in different complex diseases such as cancer, atherosclerosis, cardiovascular diseases, and age-related macular degeneration.

Associated Conditions
Vitamin E Deficiency
Associated Therapies
Skin Care

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

Phase 2
Not yet recruiting
Conditions
Fibrosis Syndrome
Lymphedema
Head &Amp; Neck Cancer
Fibrosis
Interventions
First Posted Date
2025-04-06
Last Posted Date
2025-04-06
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
250
Registration Number
NCT06912763
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

Phase 2
Not yet recruiting
Conditions
Lymphedema
Fibrosis
Interventions
First Posted Date
2024-07-10
Last Posted Date
2025-01-24
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
295
Registration Number
NCT06494111
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

Impact of Topical Pentoxifylline and Tocopherol in Treatment and Prevention of Medically-related Osteonecrosis of the Jaws

Not Applicable
Completed
Conditions
Medically Related Osteonecrosis of the Jaws
Interventions
First Posted Date
2024-05-10
Last Posted Date
2024-05-10
Lead Sponsor
University of Catania
Target Recruit Count
48
Registration Number
NCT06409546
Locations
🇮🇹

AOU Policlinico G. Rodolico, Catania, CT, Italy

Semaglutide in Nonalcoholic Fatty Liver Disease

Phase 4
Completed
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
First Posted Date
2023-04-14
Last Posted Date
2024-04-02
Lead Sponsor
Zagazig University
Target Recruit Count
180
Registration Number
NCT05813249
Locations
🇪🇬

Zagazig University, Zagazig, Sharkia, Egypt

The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis

Phase 3
Conditions
Restless Legs Syndrome
End Stage Renal Disease
Interventions
First Posted Date
2022-04-27
Last Posted Date
2022-08-24
Lead Sponsor
King Abdulaziz University
Target Recruit Count
160
Registration Number
NCT05350124

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Phase 3
Conditions
Breast Cancer Female
Interventions
First Posted Date
2021-08-23
Last Posted Date
2021-08-23
Lead Sponsor
Mahmoud Ramadan mohamed Elkazzaz
Target Recruit Count
160
Registration Number
NCT05016349

Lipid Peroxidation and Options Antioxidant Therapy for Secondary Lymphedema of the Lower Extremities

Phase 4
Completed
Conditions
Lower Extremity Lymphedema
Interventions
Drug: Micronised purified flavonoid fraction (diosmin+flavonoids expressed as hesperidin)
Other: Elastic compression
First Posted Date
2020-04-24
Last Posted Date
2022-08-04
Lead Sponsor
Ryazan State Medical University
Target Recruit Count
120
Registration Number
NCT04360889
Locations
🇷🇺

Ryazan State Medical University, Ryazan', Russian Federation

A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults

Phase 2
Completed
Conditions
Asthma
Airway Inflammation
Interventions
First Posted Date
2018-02-23
Last Posted Date
2024-02-05
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
16
Registration Number
NCT03444298
Locations
🇺🇸

UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)

Phase 3
Conditions
Medication-related Osteonecrosis of the Jaw
Bisphosphonate-related Osteonecrosis of the Jaw
Avascular Necrosis
Interventions
First Posted Date
2017-02-02
Last Posted Date
2024-05-31
Lead Sponsor
University of Washington
Target Recruit Count
100
Registration Number
NCT03040778
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

University of Washington, Seattle, Washington, United States

🇺🇸

New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, New York, United States

and more 1 locations

Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure

Phase 2
Completed
Conditions
Allergic Asthma
Interventions
First Posted Date
2016-09-22
Last Posted Date
2020-01-18
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
18
Registration Number
NCT02911688
Locations
🇺🇸

Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath